E
Barinthus Biotherapeutics plc BRNS
$1.20 $0.0151.27% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 14.97M 14.97M 14.97M 14.97M 0.00
Total Other Revenue -- -- -- -- --
Total Revenue 14.97M 14.97M 14.97M 14.97M 0.00
Cost of Revenue 8.42M 8.92M 11.70M 12.25M 11.11M
Gross Profit 6.55M 6.05M 3.27M 2.72M -11.11M
SG&A Expenses 38.79M 30.60M 24.01M 41.02M 28.42M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -436.00K -1.00M -976.00K -792.00K -582.00K
Total Operating Expenses 69.37M 64.98M 60.90M 77.70M 68.72M
Operating Income -54.40M -50.01M -45.93M -62.73M -68.72M
Income Before Tax -69.55M -65.35M -61.23M -58.75M -65.33M
Income Tax Expenses -47.00K -29.00K -44.00K -867.00K -1.47M
Earnings from Continuing Operations -69.50 -65.32 -61.18 -57.88 -63.86
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings 78.00K 88.00K 109.00K 55.00K 78.00K
Net Income -69.43M -65.23M -61.07M -57.83M -63.79M
EBIT -54.40M -50.01M -45.93M -62.73M -68.72M
EBITDA -50.66M -46.80M -43.33M -60.12M -66.12M
EPS Basic -1.73 -1.64 -1.55 -1.49 -1.65
Normalized Basic EPS -0.80 -0.74 -0.69 -0.95 -1.06
EPS Diluted -1.74 -1.65 -1.56 -1.49 -1.65
Normalized Diluted EPS -0.80 -0.74 -0.69 -0.95 -1.06
Average Basic Shares Outstanding 160.18M 158.88M 157.39M 155.82M 154.93M
Average Diluted Shares Outstanding 160.18M 158.88M 157.39M 155.82M 154.93M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --